ROUND FIVE DECISIONS
Author:
Bernard Rivers
Article Type:Article Number: 4
ABSTRACT A detailed listing and analysis is provided of which Round 5 proposals have been approved.
Based on advise from the Technical Review Panel (TRP), the Board divides eligible proposals into five Categories, as follows:
- Category 1: Approved proposals requiring no or minor clarifications, which need to be provided within 4 weeks and then given a final approval by the TRP Chair and/or Vice-Chair.
- Category 2A: Proposals that are provisionally approved subject to the required clarifications being provided within a limited timeframe (6 weeks for the applicant to respond to the TRP queries, 4 months to obtain the final TRP approval should further clarifications be requested). The primary reviewer and secondary reviewer as well as TRP Chair and /or Vice-Chair need to give final approval.
- Category 2B: Similar to Category 2A, but regarded as relatively weak, on grounds of technical merit and/or issues of feasibility and likelihood of effective implementation. The TRP took no account of the applicant country’s income level, nor of burden of disease nor of any factors other than technical merit and feasibility in grading a proposal as Category 2B. In other words, these proposals differ from Category 2A proposals only in that they have more technical weaknesses, and/or more questions as to effective implementation, and/or more required clarifications. It is important to note, however, that on balance all of the Category 2B proposals were regarded as recommended for funding, and the TRP believes that the weaknesses and clarifications could be addressed within the timeframes provided for Category 2A proposals.
- Category 3: Not approved in their present form, but applicants are encouraged to submit an improved proposal in some future Round.
- Category 4: Rejected.
If the Fund had sufficient pledges for 2005 to cover the cost of all Category 1, 2A and 2B proposals, it would have approved all of them at last week’s meeting, subject to the applicants responding acceptably to the TRP’s requests for clarification that will be sent to the applicants.
However, given that the Fund currently has insufficient pledges to cover all the Category 1, 2A and 2B proposals, the board agreed to proceed as follows, using a procedure specified at an earlier board meeting:
- Category 1 proposals are approved.
- Category 2A and 2B proposals are given a “Composite Index” of between 1 and 8 points, as follows:
- If the country has a “very high” disease burden, it receives 4 points, and otherwise it receives 1 point.
- In addition, if the country is “low-income” it receives 4 points, and if it is “lower-middle income” it receives 2 points. (“Upper-middle income” countries receive 0 extra points.)
Proposals were ranked by Category and then, for Categories 2A and 2B, they were sub-ranked by Composite Index. This led to them being grouped as in Table 5, below.
The Fund currently has enough pledges to pay for the first three groups. These have been labeled by GFO as “Immediately Approved: A, B and C”. Proposals that fall into these three groups are approved, subject to satisfactory responses being provided to the TRP queries.
The Fund does not currently have sufficient pledges to pay for proposals in the next eight groups, labeled by GFO as “Provisionally Approved D, E, F, G, H, I, J and K”. When the Fund received pledges sufficient to cover each additional group (in the order shown below), the board will approve those proposals by email.
The Secretariat will start working immediately with all provisionally approved applicants on dealing with TRP queries and negotiating grant agreements. If all those activities have been completed before pledges and actual cash contributions have been received, the actual signing of grant agreements will have to be put on hold.
However, provisionally approved proposals for which insufficient pledges are received by the end of June 2006 will lose their provisional approval and will be treated as if they had not been approved.
Table 5: Round 5 results by Category
Decision | Explanation | Number of proposals | Budget
Years 1-2 |
Budget
Years 1-5 |
Immediately Approved: A | Category 1 | 5 | $43,310,437 | $98,935,651 |
Immediately Approved: B | Category 2A, Composite Index 8 | 18 | $290,762,706 | $728,609,400 |
Immediately Approved: C | Category 2A, Composite Index 6 | 3 | $48,003,918 | $149,563,776 |
Subtotal: All “Immediately Approved” proposals | 26 | $382,077,061 | $977,108,827 | |
Provisionally approved: D | Category 2A, Composite Index 5 | 12 | $133,276,403 | $345,346,815 |
Provisionally approved: E | Category 2A, Composite Index 4 | 2 | $9,529,070 | $24,888,718 |
Provisionally approved: F | Category 2A, Composite Index 3 | 13 | $92,575,047 | $165,266,161 |
Provisionally approved: G | Category 2B, Composite Index 8 | 4 | $87,358,034 | $207,352,569 |
Provisionally approved: H | Category 2B, Composite Index 7 | 1 | $3,269,731 | $6,623,560 |
Provisionally approved: I | Category 2B, Composite Index 6 | 1 | $6,501,141 | $21,232,348 |
Provisionally approved: J | Category 2B, Composite Index 5 | 2 | $3,356,219 | $6,868,700 |
Provisionally approved: K | Category 2B, Composite Index 3 | 2 | $7,673,482 | $19,814,848 |
Subtotal: All “Provisionally Approved” proposals | 37 | $343,539,127 | $797,393,719 | |
Total: All “Immediately Approved” plus “Provisionally Approved” proposals | 63 | $725,616,188 | $1,774,502,546 | |
Not approved: L | Category 3 | 120 | $2,266,242,296 | $5,096,656,571 |
Not approved: M | Category 4 | 19 | $306,210,534 | $750,510,205 |
Subtotal: All “Not Approved” proposals | 139 | $2,572,452,830 | $5,847,166,776 | |
GRAND TOTAL | 202 | $3,298,069,018 | $7,621,669,322 |
Table 6: Round 5 results by country
Country |
Applicant |
Decision (See definitions above) |
Component |
Budget |
Budget |
Afghanistan | CCM | Provisionally approved: D | Malaria |
$17,093,334 |
$32,214,069 |
Afghanistan | CCM | Not approved: L | HIV/AIDS |
$4,663,653 |
$10,953,024 |
Afghanistan | CCM | Not approved: L | HSS |
$1,980,090 |
$4,014,470 |
Albania | CCM | Provisionally approved: F | HIV/AIDS |
$2,502,858 |
$4,990,645 |
Albania | CCM | Provisionally approved: F | TB |
$877,685 |
$1,442,028 |
Angola | CCM | Not approved: L | Malaria |
$39,227,228 |
$115,827,277 |
Armenia | CCM | Provisionally approved: K | TB |
$3,898,656 |
$7,624,135 |
Armenia | CCM | Not approved: M | Malaria |
$1,705,100 |
$2,572,700 |
Azerbaijan | CCM | Immediately Approved: A | TB |
$3,825,770 |
$9,516,200 |
Azerbaijan | CCM | Not approved: L | Malaria |
$3,179,532 |
$7,255,952 |
Bangladesh | CCM | Immediately Approved: B | TB |
$10,003,984 |
$45,977,231 |
Bangladesh | CCM | Not approved: L | HIV/AIDS |
$8,135,641 |
$23,901,394 |
Bangladesh | CCM | Not approved: L | Malaria |
$18,478,606 |
$36,993,988 |
Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka | Regional CM | Not approved: M | HIV/AIDS |
$15,464,067 |
$59,842,897 |
Belarus | CCM | Not approved: L | TB |
$13,239,086 |
$26,389,516 |
Benin | CCM | Provisionally approved: D | HIV/AIDS |
$19,709,054 |
$51,841,972 |
Benin | CCM | Not approved: L | HSS |
$6,560,978 |
$12,130,576 |
Benin | CCM | Not approved: L | Malaria |
$10,714,920 |
$52,930,467 |
Benin | CCM | Not approved: L | TB |
$3,575,918 |
$7,793,321 |
Benin, Cote d’Ivoire, Ethiopia, Nigeria, Zimbabwe | Regional org. (PSI and African Union) | Not approved: M | HIV/AIDS |
$17,304,394 |
$44,804,606 |
Bosnia Herzegovina | CCM | Provisionally approved: F | HIV/AIDS |
$4,832,387 |
$11,042,257 |
Bosnia Herzegovina | CCM | Not approved: L | TB |
$1,171,290 |
$3,157,230 |
Botswana | CCM | Provisionally approved: E | TB |
$5,515,900 |
$8,956,258 |
Brazil | CCM | Immediately Approved: C | TB |
$11,602,427 |
$27,240,000 |
Burkina Faso | CCM | Not approved: L | HIV/AIDS |
$34,432,357 |
$71,569,383 |
Burkina Faso | CCM | Not approved: L | HSS |
$5,845,718 |
$9,170,885 |
Burkina Faso | CCM | Not approved: L | Malaria |
$19,208,881 |
$27,152,602 |
Burundi | CCM | Provisionally approved: G | HIV/AIDS |
$13,053,866 |
$32,353,173 |
Burundi | CCM | Not approved: L | HSS |
$2,370,296 |
$6,566,203 |
Burundi | CCM | Not approved: L | Malaria |
$12,215,162 |
$25,401,464 |
Cambodia | CCM | Immediately Approved: B | TB |
$3,268,750 |
$9,662,024 |
Cambodia | CCM | Provisionally approved: D | HIV/AIDS |
$16,292,779 |
$34,963,654 |
Cambodia | CCM | Provisionally approved: G | HSS |
$1,841,600 |
$5,015,741 |
Cambodia | CCM | Not approved: L | Malaria |
$5,854,119 |
$11,824,545 |
Cameroon | CCM | Immediately Approved: B | HIV/AIDS |
$4,943,590 |
$12,060,019 |
Cameroon | CCM | Immediately Approved: B | Malaria |
$12,695,885 |
$21,210,595 |
Cape Verde | CCM | Not approved: L | HIV/AIDS |
$4,313,270 |
$11,659,200 |
Central African Republic | CCM | Not approved: L | HIV/AIDS |
$22,082,191 |
$36,632,357 |
Central African Republic | CCM | Not approved: L | Malaria |
$7,598,940 |
$11,990,390 |
Chad | CCM | Not approved: L | Malaria |
$17,335,833 |
$36,713,126 |
China | CCM | Immediately Approved: C | TB |
$17,814,000 |
$52,889,000 |
China | CCM | Provisionally approved: F | HIV/AIDS |
$12,544,128 |
$28,902,074 |
China | CCM | Provisionally approved: F | Malaria |
$20,096,149 |
$39,410,395 |
Colombia | CCM | Not approved: L | HIV/AIDS |
$13,338,388 |
$29,356,545 |
Comoros | CCM | Not approved: L | Malaria |
$4,110,188 |
$7,727,600 |
Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama | Regional org. (Secretary of Social Integration of Central America – SSICA) | Not approved: M | HIV/AIDS |
$13,859,280 |
$30,722,300 |
Cote d’Ivoire | Non-CCM (CARE) | Immediately Approved: B | HIV/AIDS |
$3,522,695 |
$3,522,695 |
Cote d’Ivoire | CCM | Not approved: L | HIV/AIDS |
$26,836,531 |
$47,022,390 |
Cote d’Ivoire | CCM | Not approved: L | Malaria |
$7,897,631 |
$20,272,415 |
Dem. Rep. Congo | CCM | Immediately Approved: B | TB |
$17,613,606 |
$43,716,984 |
Dem. Rep. Congo | CCM | Not approved: L | HIV/AIDS |
$60,848,374 |
$142,154,402 |
Dem. Rep. Congo | CCM | Not approved: L | HSS |
$17,947,453 |
$40,244,494 |
Dem. Rep. Congo | CCM | Not approved: L | Malaria |
$21,184,713 |
$38,608,576 |
Dem. Rep. Congo – Kasai | Sub-CCM | Not approved: M | HIV/AIDS |
$66,831,110 |
$127,046,138 |
Dem. Rep. Congo – Kasai | Sub-CCM | Not approved: M | Malaria |
$16,564,000 |
$29,779,000 |
Dem. Rep. Congo – Kasai | Sub-CCM | Not approved: M | TB |
$12,702,000 |
$23,507,000 |
Djibouti | CCM | Not approved: L | Malaria |
$2,344,000 |
$5,113,000 |
Djibouti | CCM | Not approved: L | TB |
$4,819,773 |
$10,704,374 |
Dominican Republic | CCM | Not approved: L | Malaria |
$5,368,399 |
$11,914,220 |
East Timor | CCM | Provisionally approved: D | HIV/AIDS |
$4,304,454 |
$9,110,302 |
Ecuador | CCM | Not approved: L | Malaria |
$4,097,749 |
$4,097,749 |
Egypt | CCM | Not approved: L | HIV/AIDS |
$2,185,934 |
$6,201,772 |
Egypt | CCM | Not approved: L | TB |
$4,588,252 |
$11,085,278 |
Egypt | CCM | Not approved: M | Malaria |
$2,380,000 |
$5,000,000 |
El Salvador | CCM | Not approved: L | Malaria |
$1,100,000 |
$3,000,000 |
Equatorial Guinea | CCM | Not approved: L | Malaria |
$12,906,111 |
$25,999,072 |
Eritrea | CCM | Provisionally approved: D | HIV/AIDS |
$13,139,010 |
$33,892,005 |
Eritrea | CCM | Not approved: L | HSS |
$7,697,965 |
$14,435,485 |
Eritrea | CCM | Not approved: L | Malaria |
$8,844,992 |
$17,200,208 |
Eritrea | CCM | Not approved: L | TB |
$1,443,404 |
$3,879,324 |
Ethiopia | CCM | Provisionally approved: G | Malaria |
$64,548,913 |
$150,066,528 |
Ethiopia | CCM | Not approved: L | HIV/AIDS |
$23,145,990 |
$64,497,352 |
Ethiopia | CCM | Not approved: L | HSS |
$159,999,343 |
$348,014,355 |
Ethiopia | CCM | Not approved: L | TB |
$16,440,576 |
$69,882,371 |
Gabon | CCM | Provisionally approved: E | Malaria |
$4,013,170 |
$15,932,460 |
Georgia | CCM | Not approved: L | HIV/AIDS |
$2,797,640 |
$4,654,240 |
Georgia | CCM | Not approved: L | HSS |
$436,320 |
$814,320 |
Ghana | CCM | Immediately Approved: A | TB |
$14,547,546 |
$31,471,844 |
Ghana | CCM | Provisionally approved: D | HIV/AIDS |
$31,630,830 |
$97,099,610 |
Ghana | CCM | Not approved: L | HSS |
$12,552,761 |
$19,359,341 |
Ghana, Uganda, Zimbabwe | Regional org. (TEPHINET) | Not approved: M | HSS |
$16,363,767 |
$36,318,213 |
Guatemala | CCM | Not approved: L | TB |
$5,826,331 |
$11,623,999 |
Guinea | CCM | Immediately Approved: A | TB |
$3,391,501 |
$6,225,144 |
Guinea | CCM | Not approved: L | Malaria |
$3,467,563 |
$18,987,568 |
Haiti | CCM | Immediately Approved: B | HIV/AIDS |
$19,205,567 |
$49,927,069 |
India | CCM | Not approved: L | Malaria |
$14,742,454 |
$26,448,410 |
India | CCM | Not approved: L | TB |
$7,410,000 |
$25,020,000 |
India | CCM | Not approved: M | HIV/AIDS |
$67,620,403 |
$217,625,981 |
Indonesia | CCM | Immediately Approved: C | TB |
$18,587,491 |
$69,434,776 |
Indonesia | CCM | Not approved: L | HIV/AIDS |
$13,671,879 |
$26,117,640 |
Indonesia | CCM | Not approved: L | Malaria |
$43,145,932 |
$66,543,849 |
Iran | CCM | Not approved: L | Malaria |
$8,500,000 |
$18,600,000 |
Jordan | CCM | Provisionally approved: F | TB |
$1,072,864 |
$2,782,864 |
Jordan | CCM | Not approved: L | HIV/AIDS |
$3,588,958 |
$6,899,718 |
Kazakhstan | CCM | Not approved: L | HIV/AIDS |
$2,000,295 |
$4,814,539 |
Kazakhstan | CCM | Not approved: L | TB |
$8,375,651 |
$17,558,542 |
Kenya | CCM | Provisionally approved: G | TB |
$7,913,655 |
$19,917,127 |
Kenya | CCM | Not approved: L | HIV/AIDS |
$8,893,681 |
$19,796,832 |
Kenya | CCM | Not approved: L | HSS |
$11,179,083 |
$28,076,553 |
Kenya | CCM | Not approved: L | Malaria |
$4,230,600 |
$8,427,600 |
Kosovo | CCM | Not approved: L | HIV/AIDS |
$1,701,158 |
$3,687,350 |
Kyrgyzstan | CCM | Provisionally approved: D | Malaria |
$1,692,390 |
$3,426,125 |
Kyrgyzstan | CCM | Not approved: L | TB |
$5,309,127 |
$8,863,698 |
Lesotho | CCM | Immediately Approved: B | HIV/AIDS |
$10,013,383 |
$40,346,059 |
Liberia | CCM | Not approved: L | HIV/AIDS |
$12,394,177 |
$25,714,627 |
Liberia | CCM | Not approved: L | HSS |
$14,078,615 |
$17,374,573 |
Liberia | CCM | Not approved: L | Malaria |
$15,015,748 |
$33,165,706 |
Liberia | CCM | Not approved: L | TB |
$4,750,966 |
$11,949,773 |
Macedonia | CCM | Provisionally approved: F | TB |
$1,442,489 |
$3,071,097 |
Madagascar | CCM | Not approved: L | HIV/AIDS |
$9,512,412 |
$24,957,422 |
Madagascar | CCM | Not approved: L | HSS |
$4,965,759 |
$22,599,312 |
Madagascar | CCM | Not approved: L | Malaria |
$7,974,500 |
$33,470,801 |
Madagascar | CCM | Not approved: L | TB |
$8,900,519 |
$15,249,703 |
Malawi | CCM | Immediately Approved: B | HIV/AIDS |
$7,770,655 |
$19,104,775 |
Malawi | CCM | Immediately Approved: B | HSS |
$26,965,524 |
$65,429,986 |
Maldives | CCM | Not approved: M | HIV/AIDS |
$2,016,601 |
$4,184,665 |
Mali | CCM | Not approved: L | HSS |
$7,083,766 |
$11,600,785 |
Mali | CCM | Not approved: L | Malaria |
$14,862,149 |
$36,069,482 |
Mauritania | CCM | Provisionally approved: D | HIV/AIDS |
$6,584,973 |
$15,755,931 |
Mongolia | CCM | Provisionally approved: D | HIV/AIDS |
$1,898,775 |
$4,235,640 |
Montenegro | CCM | Provisionally approved: F | HIV/AIDS |
$1,604,606 |
$2,924,696 |
Mozambique | CCM | Not approved: L | HSS |
$72,100,000 |
$106,600,000 |
Mozambique | CCM | Not approved: L | Malaria |
$32,694,480 |
$73,121,487 |
Mozambique, South Africa, Swaziland | Regional CM | Provisionally approved: I | Malaria |
$6,501,141 |
$21,232,348 |
Namibia | CCM | Immediately Approved: A | TB |
$7,222,753 |
$17,777,383 |
Namibia | CCM | Not approved: L | HIV/AIDS |
$31,341,874 |
$91,950,544 |
Namibia | CCM | Not approved: L | Malaria |
$13,136,240 |
$21,897,490 |
Nepal | CCM | Not approved: L | HIV/AIDS |
$7,717,233 |
$25,788,007 |
Nepal | CCM | Not approved: L | Malaria |
$5,352,822 |
$11,372,370 |
Nepal | CCM | Not approved: L | TB |
$3,858,926 |
$9,481,273 |
Niger | CCM | Immediately Approved: B | Malaria |
$5,148,600 |
$10,491,196 |
Niger | CCM | Provisionally approved: D | TB |
$6,326,070 |
$12,220,815 |
Niger | CCM | Not approved: L | HSS |
$7,529,467 |
$11,474,188 |
Nigeria | CCM | Immediately Approved: B | HIV/AIDS |
$46,424,283 |
$180,642,512 |
Nigeria | CCM | Immediately Approved: B | TB |
$19,217,311 |
$53,351,149 |
Nigeria | CCM | Not approved: L | HSS |
$39,505,341 |
$64,812,236 |
Nigeria | CCM | Not approved: L | Malaria |
$52,404,797 |
$179,995,004 |
Pakistan | CCM | Not approved: L | HIV/AIDS |
$13,000,477 |
$34,989,566 |
Pakistan | CCM | Not approved: L | Malaria |
$11,293,294 |
$27,059,519 |
Pakistan | CCM | Not approved: L | TB |
$15,854,040 |
$30,308,701 |
Pakistan | CCM | Not approved: M | HSS |
$9,977,880 |
$26,617,490 |
Papua New Guinea | CCM | Not approved: L | TB |
$1,975,954 |
$10,784,888 |
Paraguay | CCM | Not approved: M | HIV/AIDS |
$3,941,134 |
$9,429,262 |
Peru | CCM | Provisionally approved: F | HIV/AIDS |
$9,874,896 |
$12,967,865 |
Peru | CCM | Provisionally approved: F | TB |
$21,017,537 |
$32,545,545 |
Peru | CCM | Not approved: L | HSS |
$6,894,200 |
$17,011,200 |
Philippines | CCM | Provisionally approved: F | HIV/AIDS |
$3,011,919 |
$6,478,058 |
Philippines | CCM | Provisionally approved: F | Malaria |
$11,097,529 |
$14,308,637 |
Philippines | CCM | Not approved: L | TB |
$14,208,812 |
$45,817,584 |
Republic of Congo | CCM | Provisionally approved: D | HIV/AIDS |
$12,043,407 |
$45,553,763 |
Republic of Congo | CCM | Not approved: L | Malaria |
$17,664,123 |
$28,331,791 |
Republic of Congo | CCM | Not approved: L | TB |
$4,669,340 |
$8,138,467 |
Russian Federation | Non-CCM | Provisionally approved: K | HIV/AIDS |
$3,774,826 |
$12,190,713 |
Rwanda | CCM | Immediately Approved: A | HSS |
$14,322,867 |
$33,945,080 |
Rwanda | CCM | Immediately Approved: B | Malaria |
$28,140,772 |
$39,649,363 |
Rwanda | CCM | Not approved: L | HIV/AIDS |
$36,053,491 |
$88,300,796 |
Samoa, Cook Islands, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, Niue, Palau, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu | Regional Coordinating Mechanism | Not approved: L | HIV/AIDS |
$4,251,406 |
$9,946,332 |
Samoa, Cook Islands, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, Niue, Palau, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu | Regional Coordinating Mechanism | Not approved: L | TB |
$1,466,940 |
$4,432,060 |
Sao Tome & Principe | CCM | Provisionally approved: J | HIV/AIDS |
$584,218 |
$1,485,190 |
Senegal | CCM | Not approved: L | TB |
$8,725,379 |
$18,336,573 |
Senegal | CCM | Not approved: M | HSS |
$2,321,013 |
$3,384,233 |
Senegal | CCM | Not approved: M | Malaria |
$8,251,057 |
$12,117,141 |
Serbia | CCM | Not approved: L | HIV/AIDS |
$4,755,306 |
$8,462,528 |
Solomon Islands, Vanuatu | Regional Coordinating Mechanism | Provisionally approved: H | Malaria |
$3,269,731 |
$6,623,560 |
Somalia | Non-CCM | Not approved: L | HSS |
$1,175,365 |
$2,832,730 |
Somalia | Non-CCM | Not approved: L | Malaria |
$2,567,445 |
$14,532,272 |
South Africa | CCM | Not approved: L | HIV/AIDS |
$45,010,000 |
$108,289,000 |
South Africa | CCM | Not approved: L | HSS |
$21,851,000 |
$42,173,000 |
Sri Lanka | CCM | Not approved: L | Malaria |
$4,356,374 |
$7,290,124 |
Sri Lanka | CCM | Not approved: L | TB |
$1,700,680 |
$4,414,795 |
Sri Lanka | CCM | Not approved: M | HIV/AIDS |
$2,607,594 |
$5,357,285 |
Sudan | CCM | Not approved: L | HIV/AIDS |
$29,424,335 |
$112,553,275 |
Sudan | CCM | Not approved: L | Malaria |
$24,019,599 |
$46,323,995 |
Sudan | CCM | Not approved: L | TB |
$6,830,013 |
$15,410,468 |
Sudan | CCM | Not approved: M | HSS |
$42,800,000 |
$105,860,000 |
Sudan (Southern Sector) | Sub-CCM | Immediately Approved: B | TB |
$8,592,197 |
$27,568,526 |
Sudan (Southern Sector) | Sub-CCM | Not approved: L | HSS |
$25,929,249 |
$68,455,557 |
Suriname | CCM | Provisionally approved: F | HIV/AIDS |
$2,600,000 |
$4,400,000 |
Tajikistan | CCM | Provisionally approved: J | Malaria |
$2,772,001 |
$5,383,510 |
Tanzania | CCM | Not approved: L | HIV/AIDS |
$9,204,276 |
$11,932,883 |
Tanzania | CCM | Not approved: L | HSS |
$22,869,642 |
$34,866,750 |
Tanzania Zanzibar | CCM | Not approved: L | HIV/AIDS |
$12,722,287 |
$30,817,709 |
Thailand | CCM | Not approved: L | HIV/AIDS |
$5,920,079 |
$16,886,287 |
The Gambia | CCM | Provisionally approved: D | TB |
$2,561,327 |
$5,032,929 |
The Gambia | CCM | Not approved: L | HIV/AIDS |
$7,842,275 |
$14,733,869 |
The Gambia | CCM | Not approved: L | Malaria |
$18,169,122 |
$40,473,141 |
Tunisia | CCM | Not approved: L | HIV/AIDS |
$10,007,400 |
$20,898,000 |
Turkey | CCM | Not approved: M | Malaria |
$2,387,990 |
$4,784,490 |
Turkey | CCM | Not approved: M | TB |
$1,113,144 |
$1,556,804 |
Uganda | CCM | Not approved: L | HIV/AIDS |
$5,857,397 |
$17,746,651 |
Uganda | CCM | Not approved: L | HSS |
$5,605,994 |
$10,942,316 |
Uganda | CCM | Not approved: L | Malaria |
$49,494,235 |
$90,219,700 |
Vietnam | CCM | Not approved: L | HIV/AIDS |
$6,500,000 |
$20,000,000 |
Vietnam | CCM | Not approved: L | TB |
$7,037,112 |
$18,718,344 |
Yemen | CCM | Not approved: L | Malaria |
$15,889,956 |
$41,763,366 |
Zambia | CCM | Not approved: L | HIV/AIDS |
$481,308,000 |
$1,033,420,000 |
Zambia | CCM | Not approved: L | HSS |
$11,042,000 |
$34,940,000 |
Zambia | CCM | Not approved: L | Malaria |
$22,147,000 |
$41,200,000 |
Zambia | CCM | Not approved: L | TB |
$98,610,000 |
$246,525,000 |
Zimbabwe | CCM | Immediately Approved: B | HIV/AIDS |
$35,931,159 |
$62,478,891 |
Zimbabwe | CCM | Immediately Approved: B | Malaria |
$21,217,469 |
$29,998,400 |
Zimbabwe | CCM | Immediately Approved: B | TB |
$10,087,276 |
$13,471,926 |
Information on Round 5 grants is also available on the Global Fund web site atĀ www.theglobalfund.org/en/about/board/eleventh.
An applicant may appeal the board’s decision if the applicant submitted an eligible proposal for a particular component in both Round 4 and Round 5 and was not approved in either case. The appeal must show that the recommendation made by the TRP regarding the Round 5 proposal was based on a “significant and obvious” error. The appeal must be filed with the Secretariat no later than 28 days from when the applicant receives written notice of the board’s Round 5 decision. For further details regarding the appeals procedure, seeĀ www.theglobalfund.org/en/apply/proposals/appeals.